It is notable that the drugs acting on this pathway enhance mutant huntingtin clearance via an mTOR-independent autophagy pathway, decrease mutant huntingtin aggregate levels and confer protection against toxicity in HD cell, fly and zebrafish models [24,77]. This evidence concerns the gene HTT and Huntington disease.